In “Double Indemnity,” the Depression era masterpiece about insurance fraud and murder, the anti-hero Walter Huff quickly ...

Nina King says that Ozempic's rise could shift beauty standards away from thinness as it becomes more accessible.

A woman from Long Island was traveling over the holidays when she lost a beloved piece of jewelry that had been in her family for nearly a century -- and a group of strangers worked together to help ...

A scientist tried to discredit the theory that ultra-processed foods are killing us. Instead, he overturned his own ...

Projections about the coming year assume market shifts will be dictated by Donald Trump. But the global economy is unlikely to revolve around the US ...

The future of AI, Ozempic, Europe, bird flu and all your resolutions.

Leading market strategists say it’s time to take a hard look at your portfolio and sell stocks that have been good to you.

Novo Nordisk’s Ozempic and Wegovy continue to outpace Eli Lilly’s Mounjaro and Zepbound, even though the latter are demonstrably more effective in clinical trials. The most recent earnings reports ...

Between Novo Nordisk's (NVO) slightly disappointing results for its latest GLP-1 candidate, CagriSema, and questions that remain about Amgen's (AMGN) highly anticipated once-monthly injectable ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Global Partners LP (GLP) reports significant gains in key financial metrics and strategic expansions, despite rising expenses. WALTHAM, Mass., November 08, 2024--Global Partners LP (NYSE ...

Gary Stibel is the founder, CEO, and managing partner of the New England Consulting Group. With over half a century of experience, Gary has worked in nearly every segment of the healthcare and life ...